Back to Journals » Clinical Ophthalmology » Volume 4

Original Research

Use of nepafenac (Nevanac®) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections

       
Total article views   HTML views PDF downloads Totals
13,479 Dovepress* 11,101+ 2,060 13,161
PubMed Central* 2,378 380 2,758
Totals 13,479 2,440 15,919
*Since 28 October 2010
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed and Google Scholar